Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (1401-1410 of 3,827) with videos related to

Pageof 383
Sort By:
Cancer Cell|June 15, 2004
Tyrosine kinase inhibitors: why does the current process of clinical development not apply to them?Carlos L Arteaga, Jose Baselga
Cancer Cell|June 15, 2004
Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cellsSvetlana Avdulov, Shunan Li, Van Michalek, et al.
Cancer Cell|June 15, 2004
Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARgammaMichael Hedvat, Anjali Jain, Dennis A Carson, et al.
Cancer Cell|October 19, 2004
Guilty as charged: B-RAF is a human oncogeneMathew J Garnett, Richard Marais
Cancer Cell|October 19, 2004
The convergence of cancer prevention and therapy in early-phase clinical drug developmentJames L Abbruzzese, Scott M Lippman
Cancer Cell|October 19, 2004
PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasisRenhai Cao, Meit A Björndahl, Piotr Religa, et al.
Cancer Cell|October 19, 2004
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastomaAntonella Tacconelli, Antonietta R Farina, Lucia Cappabianca, et al.
Cancer Cell|June 15, 2004
Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypesRatna K Vadlamudi, Rozita Bagheri-Yarmand, Zhibo Yang, et al.
Cancer Cell|March 5, 2004
PP2A fulfills its promises as tumor suppressor: which subunits are important?Christine Van Hoof, Jozef Goris
Cancer Cell|March 5, 2004
Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasisAnna D'Angelo, Livia Garzia, Alessandra André, et al.
Pageof 383

Showing results (1401-1410 of 3,827) with videos related to

Sort By:
Pageof 383
Cancer Cell|June 15, 2004
Tyrosine kinase inhibitors: why does the current process of clinical development not apply to them?Carlos L Arteaga, Jose Baselga
Cancer Cell|June 15, 2004
Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cellsSvetlana Avdulov, Shunan Li, Van Michalek, et al.
Cancer Cell|June 15, 2004
Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARgammaMichael Hedvat, Anjali Jain, Dennis A Carson, et al.
Cancer Cell|October 19, 2004
Guilty as charged: B-RAF is a human oncogeneMathew J Garnett, Richard Marais
Cancer Cell|October 19, 2004
The convergence of cancer prevention and therapy in early-phase clinical drug developmentJames L Abbruzzese, Scott M Lippman
Cancer Cell|October 19, 2004
PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasisRenhai Cao, Meit A Björndahl, Piotr Religa, et al.
Cancer Cell|October 19, 2004
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastomaAntonella Tacconelli, Antonietta R Farina, Lucia Cappabianca, et al.
Cancer Cell|June 15, 2004
Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypesRatna K Vadlamudi, Rozita Bagheri-Yarmand, Zhibo Yang, et al.
Cancer Cell|March 5, 2004
PP2A fulfills its promises as tumor suppressor: which subunits are important?Christine Van Hoof, Jozef Goris
Cancer Cell|March 5, 2004
Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasisAnna D'Angelo, Livia Garzia, Alessandra André, et al.
Pageof 383